McDermott should be bought by long-term investors, says Broadpoint AmTech
Broadpoint AmTech believes that McDermott's current healthy long-term cycle and the growth of its government business are not currently discounted in the stock. The firm "strongly" reiterates its Buy rating on the shares. :theflyonthewall.com
News For MDR From The Last 14 Days
Check below for free stories on MDR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
